资产负债表（NovaBay Pharmaceuticals Inc）
| 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||||
| 现金及现金等价物(元) | 751,000.00 | 1,823,000.00 | 3,130,000.00 | 3,472,000.00 | 4,414,000.00 | 3,746,000.00 | 5,362,000.00 | 3,868,000.00 | 3,931,000.00 | 5,641,000.00 |
| 应收账款及票据(元) | 547,000.00 | 734,000.00 | 759,000.00 | 916,000.00 | 2,623,000.00 | 1,835,000.00 | 1,973,000.00 | 2,133,000.00 | 1,098,000.00 | 2,300,000.00 |
| 预付款项及其他应收款流动(元) | 255,000.00 | 371,000.00 | 388,000.00 | 333,000.00 | 519,000.00 | 516,000.00 | 560,000.00 | 544,000.00 | 629,000.00 | 752,000.00 |
| 存货(元) | 700,000.00 | 663,000.00 | 2,877,000.00 | 3,493,000.00 | 3,660,000.00 | 3,797,000.00 | 3,437,000.00 | 4,068,000.00 | 3,801,000.00 | 3,785,000.00 |
| 流动资产合计(元) | 2,253,000.00 | 3,591,000.00 | 7,154,000.00 | 8,214,000.00 | 11,216,000.00 | 9,894,000.00 | 11,332,000.00 | 10,613,000.00 | 9,459,000.00 | 12,478,000.00 |
| 非流动资产： | ||||||||||
| 物业、厂房及设备(元) | 68,000.00 | 77,000.00 | 87,000.00 | 97,000.00 | 108,000.00 | 119,000.00 | 119,000.00 | 217,000.00 | 166,000.00 | 187,000.00 |
| 无形资产(元) | - | - | - | 2,166,000.00 | 2,204,000.00 | 2,242,000.00 | 2,280,000.00 | 4,928,000.00 | 5,018,000.00 | 5,109,000.00 |
| 商誉(元) | - | - | - | 348,000.00 | 348,000.00 | 348,000.00 | 348,000.00 | 4,528,000.00 | 4,528,000.00 | 4,528,000.00 |
| 非流动资产其他项目(元) | 1,604,000.00 | 1,689,000.00 | 1,793,000.00 | 2,027,000.00 | 2,132,000.00 | 2,222,000.00 | 2,320,000.00 | 2,090,000.00 | 2,373,000.00 | 2,492,000.00 |
| 非流动资产合计(元) | 1,672,000.00 | 1,766,000.00 | 1,880,000.00 | 4,638,000.00 | 4,792,000.00 | 4,931,000.00 | 5,067,000.00 | 11,763,000.00 | 12,085,000.00 | 12,316,000.00 |
| 总资产(元) | 3,925,000.00 | 5,357,000.00 | 9,034,000.00 | 12,852,000.00 | 16,008,000.00 | 14,825,000.00 | 16,399,000.00 | 22,376,000.00 | 21,544,000.00 | 24,794,000.00 |
| 流动负债： | ||||||||||
| 短期债务及长期负债本期部分(元) | 41,000.00 | 34,000.00 | - | 1,270,000.00 | 1,185,000.00 | - | - | - | - | - |
| 融资租赁负债流动(元) | 382,000.00 | 375,000.00 | 495,000.00 | 485,000.00 | 476,000.00 | 466,000.00 | 453,000.00 | 445,000.00 | 470,000.00 | 465,000.00 |
| 应付账款及票据(元) | 1,890,000.00 | 2,090,000.00 | 2,267,000.00 | 947,000.00 | 1,481,000.00 | 1,148,000.00 | 1,080,000.00 | 1,097,000.00 | 930,000.00 | 1,556,000.00 |
| 其他应付款及应计费用(元) | 1,297,000.00 | 1,266,000.00 | 1,516,000.00 | 1,869,000.00 | 2,755,000.00 | 2,809,000.00 | 2,724,000.00 | 2,168,000.00 | 2,257,000.00 | 2,763,000.00 |
| 衍生工具负债流动(元) | - | 159,000.00 | - | - | 169,000.00 | - | - | - | - | - |
| 流动负债合计(元) | 3,610,000.00 | 3,924,000.00 | 4,278,000.00 | 4,571,000.00 | 6,066,000.00 | 4,423,000.00 | 4,257,000.00 | 3,710,000.00 | 3,657,000.00 | 4,784,000.00 |
| 非流动负债： | ||||||||||
| 融资租赁负债非流动(元) | 932,000.00 | 1,041,000.00 | 1,108,000.00 | 1,244,000.00 | 1,379,000.00 | 1,512,000.00 | 1,588,000.00 | 1,713,000.00 | 1,800,000.00 | 1,922,000.00 |
| 衍生工具负债非流动(元) | - | 232,000.00 | 334,000.00 | - | - | - | - | 2,827,000.00 | - | - |
| 非流动负债其他项目(元) | - | - | - | - | - | - | - | 342,000.00 | 342,000.00 | 342,000.00 |
| 非流动负债合计(元) | 932,000.00 | 1,273,000.00 | 1,442,000.00 | 1,244,000.00 | 1,379,000.00 | 1,512,000.00 | 1,588,000.00 | 4,882,000.00 | 2,142,000.00 | 2,264,000.00 |
| 总负债(元) | 4,542,000.00 | 5,197,000.00 | 5,720,000.00 | 5,815,000.00 | 7,445,000.00 | 5,935,000.00 | 5,845,000.00 | 8,592,000.00 | 5,799,000.00 | 7,048,000.00 |
| 股东权益： | ||||||||||
| 普通股(元) | 13,000.00 | 320,000.00 | 112,000.00 | 65,000.00 | 673,000.00 | 652,000.00 | 652,000.00 | 650,000.00 | 535,000.00 | 514,000.00 |
| 优先股(元) | 6,000.00 | 1,485,000.00 | 1,950,000.00 | 1,977,000.00 | 2,124,000.00 | 2,973,000.00 | - | 570,000.00 | 570,000.00 | 609,000.00 |
| 股本溢价(元) | 179,392,000.00 | 176,798,000.00 | 176,101,000.00 | 170,675,000.00 | 169,689,000.00 | 165,156,000.00 | 165,081,000.00 | 162,510,000.00 | 158,793,000.00 | 158,621,000.00 |
| 留存收益(元) | -180,028,000.00 | -178,443,000.00 | -174,849,000.00 | -165,680,000.00 | -163,923,000.00 | -159,891,000.00 | -158,152,000.00 | -149,946,000.00 | -144,153,000.00 | -141,998,000.00 |
| 归属于母公司股东权益其他项目(元) | - | - | - | - | - | - | 2,973,000.00 | - | - | - |
| 归属于母公司股东权益(元) | -617,000.00 | 160,000.00 | 3,314,000.00 | 7,037,000.00 | 8,563,000.00 | 8,890,000.00 | 10,554,000.00 | 13,784,000.00 | 15,745,000.00 | 17,746,000.00 |
| 股东权益合计(元) | -617,000.00 | 160,000.00 | 3,314,000.00 | 7,037,000.00 | 8,563,000.00 | 8,890,000.00 | 10,554,000.00 | 13,784,000.00 | 15,745,000.00 | 17,746,000.00 |
| 负债及股东权益合计(元) | 3,925,000.00 | 5,357,000.00 | 9,034,000.00 | 12,852,000.00 | 16,008,000.00 | 14,825,000.00 | 16,399,000.00 | 22,376,000.00 | 21,544,000.00 | 24,794,000.00 |
| 公告日期 | 2024-08-13 | 2024-05-09 | 2024-03-26 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-31 | 2022-11-14 | 2022-08-11 | 2022-05-12 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||||
| 核数师 |